NYSE: FSNBFusion Acquisition Corp Ii Stock
$10.32+0.00 (+0%)
Updated May 26, 2023
FSNB Price
$10.32
Fair Value Price
N/A
Market Cap
$645.00M
52 Week Low
$9.77
52 Week High
$10.43
P/E
41.28x
P/B
-30.77x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$15.55M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.04
Operating Cash Flow
-$755k
Beta
0
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
FSNB Overview
Fusion Acquisition Corp. II is a "blank check" company formed to effect mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations. It targets fintech companies. Fusion Acquisition was incorporated in 2021 and is based in New York, NY.
Zen Score
–
Industry Average (7)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how FSNB scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
FSNB was unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
FSNB is good value based on its earnings relative to its share price (41.28x), compared to the US market average (54.23x)
P/E vs Market Valuation
FSNB is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more FSNB due diligence checks available for Premium users.
Be the first to know about important FSNB news, forecast changes, insider trades & much more!
FSNB News
Valuation
FSNB price to earnings (PE)
For valuing profitable companies with steady earnings
Company
41.28x
Industry
41.44x
Market
54.23x
FSNB is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
FSNB is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
FSNB price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-30.77x
Industry
-27.13x
FSNB's financial health
Profit margin
Revenue
$0.0
Net Income
$2.5M
Profit Margin
0%
FSNB's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$502.9M
Liabilities
$21.8M
Debt to equity
-1.04
FSNB's short-term liabilities ($1.21M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
FSNB's long-term liabilities ($20.62M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
FSNB's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
FSNB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$346.3k
Investing
$693.8k
Financing
$0.0
FSNB's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
FSNB vs Shell Company Stocks
Fusion Acquisition Ii Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.